Helen of Troy (HELE) Down 12.1% Since Last Earnings Report: Can It Rebound?

In This Article:

A month has gone by since the last earnings report for Helen of Troy (HELE). Shares have lost about 12.1% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Helen of Troy due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.

Helen of Troy Lags Q1 Earnings Estimates, Cuts FY25 View

Helen of Troy posted drab first-quarter fiscal 2025 results, with the top and the bottom line missing the Zacks Consensus Estimate and declining year over year. Management lowered its fiscal 2025 outlook.

Quarter in Detail

Adjusted earnings of 99 cents per share missed the Zacks Consensus Estimate of $1.59 and declined 49% year over year. The downside was due to reduced adjusted operating income and higher tax rates. These were somewhat countered by lower interest expense.

Consolidated net sales of $416.8 million missed the Zacks Consensus Estimate of $446.2 million. Also, the metric fell 12.2% from the year-ago quarter’s tally. This downtick was mainly caused by reduced sales of hair appliances and prestige hair care products in the Beauty & Wellness unit and lower demand for humidifiers. In the Home & Outdoor sector, the decline was primarily due to lower orders from retail customers and challenges related to shipping disruptions at the company's Tennessee distribution facility. The decline in net sales was partly mitigated by international expansion and increased sales of fans within the Beauty & Wellness category.

The consolidated gross profit margin expanded 330 bps to 48.7%. A favorable segment mix in the Home & Outdoor segment mainly drove the rise in consolidated gross profit margin. Lower year-over-year inventory obsolescence expenses and reduced commodity and product costs resulting from Project Pegasus initiatives contributed positively. However, these gains were partially mitigated by less favorable product and customer mixes within the segments and increased sales dilution from trade discounts, allowances and promotional activities in the Beauty & Wellness sector. We expected the gross profit margin to expand 100 bps to 46.4% in the fiscal first quarter.

The consolidated SG&A ratio increased 560 bps to 40.9%. The rise in such costs was mainly due to increased spending on marketing, additional costs and operational inefficiencies resulting from startup issues with automation at the Tennessee distribution facility, higher depreciation charges and unfavorable expenses related to health insurance and product liability. The downside in net sales led to less favorable operating leverage. Nevertheless, reduced expenses for share-based compensation offered some respite. Adjusted operating income declined 35.1% to $43 million, with the adjusted operating margin contracting 360 bps to 10.3%.